Total Neoadjuvant Chemoradiotherapy Plus Anti-PD-1 in Subperitoneal Patients With Locally Advanced Rectal CancerPatients With Locally Advanced Rectal Cancer: A Prospective, Single Arm, Exploratory Study

Clinical trial NCT05998122 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05998122
Sponsor: The First Hospital of Jilin University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Rectal Cancer Total Neoadjuvant Treatment Anti-PD-1

Start date: 2023-09-01
Primary completion: 2026-12-31
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.